These results provided us with clues to better understand SCD5 from the perspective of bioinformatics and highlighted the clinical importance of SCD5 in breast cancer, especially triple negative breast cancer (TNBC). This evidence concerns the gene SCD5 and triple-negative breast carcinoma.